Back to Oncology
Oncologyv1999Evidence-Based

PaP Score — Palliative Prognostic Score

The PaP score estimates 30-day survival probability in advanced solid-tumor patients from 6 variables (dyspnea, anorexia, KPS, clinician prediction, WBC, lymphocyte %). Total 0-17.5.

Clinical Input Parameters

Range: 500 — 100000
Range: 0 — 100
Clinical Assessment
Awaiting Parameters
pap score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The PaP Score — Palliative Prognostic Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

PaP = dyspnea (0/1.0) + anorexia (0/1.5) + KPS (>=50: 0; 30-40: 0; 10-20: 2.5) + clinician prediction of survival in weeks (>12: 0; 11-12: 2.0; 9-10: 2.5; 7-8: 2.5; 5-6: 4.5; 3-4: 6.0; 1-2: 8.5) + WBC (4800-8500: 0; 8501-11000: 0.5; >11000: 1.5) + lymphocytes % (20-40: 0; 12-19.9: 1.0; <12: 2.5). Range 0-17.5.

Clinical Pearls & Practice Notes

  • Risk groups: A 0-5.5 (>70% 30-day survival), B 5.6-11.0 (30-70%), C 11.1-17.5 (<30%).
  • WBC below 4800 is scored 0 (original table does not stratify leukopenia).

Evidence & Literature Citations

  1. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):231-239.
  2. Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):240-247.

Score Interpretation Ranges

Group A0 – 5.5 pts

Group A (0-5.5): >70% 30-day survival

Group B5.5 – 11 pts

Group B (5.6-11.0): 30-70% 30-day survival

Group C11 – 17.5 pts

Group C (11.1-17.5): <30% 30-day survival

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.